Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
T-1101 by Taivex Therapeutics for Solid Tumor: Likelihood of Approval
T-1101 is under clinical development by Taivex Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Data Insights
T-1101 by Taivex Therapeutics for Advanced Malignancy: Likelihood of Approval
T-1101 is under clinical development by Taivex Therapeutics and currently in Phase I for Advanced Malignancy. According to GlobalData, Phase...